<sup>188</sup> Rhenium, the New Workhorse of Radio Nuclide Therapy: Concepts to Clinical Use

Authors

  • Richard P. Baum THERANOSTICS Center for Molecular Radiotherapy and Molecular Imaging (PET/CT) ENETS Center of Excellence
  • Thomas W. Barber Department of Nuclear Medicine and PET, and Department of Medicine, Monash University, The Alfred Hospital, Melbourne, Australia

Keywords:

188Rhenium, Nuclide

Abstract

Editorial

Downloads

Published

2017-07-31

Issue

2017: Special Issue - 188Rhenium, the new Workhorse of Radio Nuclide Therapy: Concepts to Clinical Use

Section

Articles

License

Policy for Journals/Articles with Open Access

Authors who publish with this journal agree to the following terms:
    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

  1. Authors are permitted and encouraged to post links to their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work

Policy for Journals / Manuscript with Paid Access

Authors who publish with this journal agree to the following terms:
    1. Publisher retain copyright .

  1. Authors are permitted and encouraged to post links to their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work .